Multicenter, randomized trial comparing a combined gemcitabine and cisplatin 3-week regimen with a 4-week regimen in non-small cell lung cancer (NSCLC) patients

M. Liao(Union Hospital), L. Wang(Union Hospital), Hui Wan(Jilin University), Yanjie Zhu(Chinese Academy of Sciences), Belinda J. Hall(Union Hospital), L. Li(Union Hospital), Shaoqing Yu(Intelligent Health (United Kingdom))
Journal of Clinical Oncology
June 20, 2006
Cited by 0


Related Papers